Xaluritamig is under clinical development by Amgen and currently in Phase I for Prostate Cancer. According to GlobalData, Phase I drugs for Prostate Cancer have a 76% phase transition success rate ...
PF-07054894 is under development for the treatment of inflammatory bowel disease and ulcerative colitis. It is administered through oral route. The drug candidate is a new molecular entity. It acts by ...
Hosted on MSN1mon
Trump signs MOU with Biden White House for next phase of transitionwhich will allow officials to meet with counterparts at departments and agencies ahead of the January transition of power. Pushpa 2 box office Day 13: Allu Arjun's film remains unstoppable People ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback